Catalyst Wire Dossier Catalyst Wire Dossier

BIBF 1120 Soft Gelatine Capsule Charge 2

nintedanib · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIBF 1120 Soft Gelatine Capsule Charge 2, covering 2014-07-18 to 2014-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Relative Bioavailability of BIBF 1120 Soft Gelatine Capsules Charge 1, BIBF 1120 Soft Gelatine Capsules Charge 2 and BIBF 1120 Drinking Solution in Healthy Male Volunteers [Phase 1]

See pricing